{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "The Peptide Record — Updates",
  "home_page_url": "https://thepeptiderecord.org/updates/",
  "feed_url": "https://thepeptiderecord.org/updates/feed.json",
  "description": "What changed on The Peptide Record: new Library pages, Register corrections, legal-status changes, and FDA warning-letter findings.",
  "items": [
    {
      "id": "2026-09-12-12 new Library pages: fertility hormones, lipoglycopeptide antibiotics, EPO/CSF drugs",
      "url": "https://thepeptiderecord.org/library/",
      "title": "12 new Library pages: fertility hormones, lipoglycopeptide antibiotics, EPO/CSF drugs",
      "content_text": "Follitropin Alfa/Beta, Menotropins, Lutropin Alfa, Choriogonadotropin Alfa, and Thyrotropin Alfa join the fertility/diagnostic-hormone cluster; Telavancin, Dalbavancin, and Oritavancin cover the lipoglycopeptide antibiotics; Epoetin Alfa, Darbepoetin Alfa, Filgrastim, and Pegfilgrastim cover the erythropoietin and colony-stimulating-factor drugs. The Library now stands at 111 ingredient pages.",
      "date_published": "2026-09-12T12:00:00.000Z",
      "tags": [
        "library"
      ]
    },
    {
      "id": "2026-09-12-Correction: two duplicate Register assessments merged",
      "url": "https://thepeptiderecord.org/register/",
      "title": "Correction: two duplicate Register assessments merged",
      "content_text": "Ancient Nutrition and Garden of Life's collagen-peptide products had each been independently assessed twice in separate research rounds without a duplicate check. Both duplicates have been merged into a single, more detailed entry, and the public \"products assessed\" count corrected down from 139 to 137.",
      "date_published": "2026-09-12T12:00:00.000Z",
      "tags": [
        "correction"
      ]
    },
    {
      "id": "2026-09-12-Two standing automations now watch this site for us",
      "url": "https://thepeptiderecord.org/about/",
      "title": "Two standing automations now watch this site for us",
      "content_text": "A weekly pass re-checks Register categories for new or reassessment-due brands, and a separate weekly pass re-checks existing FDA warning-letter findings for status changes (closeout letters, new letters) — both land Sunday evening for Monday-morning review, and nothing publishes without a human check first.",
      "date_published": "2026-09-12T12:00:00.000Z",
      "tags": [
        "meta"
      ]
    }
  ]
}